Interventional Cardiology Devices – Market Insights – Japan

The Japanese IC device market is intensely competitive and positioned for significant growth, fueled by rising procedure volumes for complex CAD cases and the adoption of cutting-edge devices and technologies. Strong clinical evidence, particularly for coronary IVL, will drive market momentum further. Moreover, the introduction of innovative products and advanced diagnostic methods will broaden the eligible patient base. However, market revenues will be offset by eroding ASPs due to biennial reimbursement cuts by the MHLW, resulting in overall market contraction over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in Japan from 2019 through 2033.

The coronary stent segment remains intensely competitive, with leading companies continually advancing their flagship devices through innovative updates to maintain their leadership.

What are the market share dynamics among the three major competitors in the highly lucrative DES device market?

What competitive strategies are companies using to capture market share in this space, and how are ASPs being impacted by the strong competition?

Advancements in technology are transforming the diagnosis and treatment of complex PCIs.

How will the market landscape for coronary stents evolve over the next few years with the adoption of BRS?

What advancements are anticipated in the developmental pipeline for the next generation of BRS?

The introduction of intravascular lithotripsy has revolutionized the treatment of calcified coronary lesions and vessel preparation prior to stenting.

How has the commercialization of coronary lithotripsy impacted the use of other products used in the IC device space?

How is reimbursement changing for coronary lithotripsy, and how will this affect adoption of this technology?

The growing adoption of alternative coronary physiology modalities is set to reshape the diagnostic market landscape.

What is the impact of the latest generation of alternative coronary physiology modalities, such imaging-based FFR_angio and FFR_CT, on existing intravascular imaging technologies, including traditional FFR and IVUS?

What is the expected impact of emerging balloon-based technologies such as DCBs?

How are new clinical trials impacting IC device segments, procedures, competitors, and products?

The biennial MHLW reimbursement cuts are poised to create ongoing headwinds for the Japanese IC device market, significantly impacting revenue growth, pricing strategies, and market dynamics over time.